Erratum: Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain (European Journal of Pharmacology 668 (2011) (155-162) DOI: 10.1016/j.ejphar.2011.06.032);Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain

European Journal of Pharmacology

Volumn 668, Issue 1-2, 2011, Pages 155-162

  Nirogi, Ramakrishna ^a   Jayarajan, Pradeep ^a   Abraham, Renny ^a   Shanmuganathan, Dhanalakshmi ^a   Rasheed, Mohammed Abdul ^a   Royapalley, Praveen Kumar ^a   Goura, Venkatesh ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

A 366833; Complete Freund's adjuvant; Diabetes neuropathy; Nerve ligation model; Nicotinic acetylcholine receptor agonist; Vincristine

Indexed keywords

5 [3,6 DIAZABICYCLO[3.2.0]HEPTAN 6 YL]NICOTINONITRILE; A 366833; ANTINOCICEPTIVE AGENT; FREUND ADJUVANT; GABAPENTIN; INDOMETACIN; NICOTINIC AGENT; UNCLASSIFIED DRUG; VINCRISTINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; HYPERALGESIA; INFLAMMATORY PAIN; MALE; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SINGLE DRUG DOSE;

EID: 80052063236     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.10.014     Document Type: Erratum

References (49)

1. J.Md. Abdin, N. Morioka, K. Morita, T. Kitayama, T. Kitayama, S. Kitayama, T. Nakashima, and T. Dohi Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord Life Sci. 80 2006 9 16 (Pubitemid 44809291)
2. N. Attal, G. Cruccu, M. Haanpää, P. Hansson, T.S. Jensen, T. Nurmikko, C. Sampaio, S. Sindrup, and P. Wiffen EFNS guidelines on pharmacological treatment of neuropathic pain Eur. J. Neurol. 13 2006 1153 1169 (Pubitemid 44581463)
3. N. Authier, J.P. Gillet, J. Fialip, A. Eschalier, and F. Coudore A new animal model of vincristine induced nociceptive peripheral neuropathy Neurotoxicology 24 2003 797 805 (Pubitemid 37486255)
4. A.W. Bannon, M.W. Decker, M.W. Holladay, P. Curzon, D. Donnelly-Roberts, P.S. Puttfarcken, R.S. Bitner, A. Diaz, A.H. Dickenson, R.D. Porsolt, M. Williams, and S.P. Arneric Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors Science 279 1998 77 81 (Pubitemid 28079158)
5. A.W. Bannon, M.W. Decker, D.J.B. Kim, J.E. Campbell, and S.P. Arneric ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain Brain Res. 801 1998 158 163 (Pubitemid 28401659)
6. A.W. Bannon, M.W. Decker, P. Curzon, M.J. Buckley, D.J.B. Kim, R.J. Radek, J.K. Lynch, J.T. Wasicak, N.-H. Lin, W.H. Arnold, M.W. Holladay, M. Williams, and S.P. Arneric ABT-594 [(R)-5-2-azetidinylmethoxy)-2-chloropyridine] : a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization J. Pharmacol. Exp. Ther. 285 1998 787 794 (Pubitemid 28237462)
7. R.F. Bell, J.B. Dahl, R.A. Moore, and E. Kalso Peri-operative ketamine for acute postoperative pain: a quantitative and qualitative systematic review (Cochrane review) Acta Anaesthesiol. Scand. 49 2005 1405 1428 (Pubitemid 41565020)
8. G.J. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
9. T. Bordet, B. Buisson, M. Michaud, J.L. Abitbol, F. Marchand, J. Grist, E. Andriambeloson, M. Malcangio, and R.M. Pruss Specific antinociceptive activity of Cholest-4-en-3-one, Oxime (TRO19622) in experimental models of painful diabetic and chemotherapy induced neuropathy J. Pharmacol. Exp. Ther. 326 2008 623 632
10. S. Bosnjak, S. Jelic, S. Susnjar, and V. Luki Gabapentin for relief of neuropathic pain related to anticancer treatment: a preliminary study J. Chemother. 14 2002 214 219 (Pubitemid 34454638)
11. J.J. Buccafusco Neuronal nicotinic receptor subtypes: defining therapeutic targets Mol. Interv. 4 2004 285 295 (Pubitemid 39429936)
12. W.H. Bunnelle, M.J. Dart, and M.R. Schrimpf Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity Curr. Top. Med. Chem. 4 2004 299 334 (Pubitemid 38849362)
13. X. Chen, and J.D. Levine Mechanically -evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat Mol. Pain 3 2007 5
14. B.A. Chizh, and P.M. Headley NMDA antagonists and neuropathic pains-multiple drug targets and multiple uses Curr. Pharm. Des. 11 2005 2977 2994 (Pubitemid 41158087)
15. P. Curzon, A.L. Nikkel, A.W. Bannon, S.P. Arneric, and M.W. Decker Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (±)-epibatidine in rats J. Pharmacol. Exp. Ther. 28 1998 847 853 (Pubitemid 29131591)
16. M.I. Damaj, C. Fonck, M.J. Marks, P. Deshpande, C. Labarca, H.A. Lester, A.C. Collins, and B.R. Martin Genetic approaches identify differential roles for α4β2 nicotinic receptors in acute models of antinoception in Mice J. Pharmacol. Exp. Ther. 321 2007 1161 1169 (Pubitemid 46762713)
17. I. Decosterd, A. Allchorne, and C.J. Woolf Differential analgesic sensitivity of two distinct neuropathic pain models Anesth. Analg. 99 2004 457 463 (Pubitemid 38970420)
18. M. Dobretsov, S.L. Hastings, D. Romanovsky, J.R. Stimers, and J.M. Zhang Mechanical hyperalgesia in rat models of systemic and local hyperalgycemia Brain Res. 960 2003 174 183 (Pubitemid 36044574)
19. T. Dowdall, I. Robinson, and T.F. Meert Comparison of five different rat models of peripheral nerve injury Pharmacol. Biochem. Behav. 80 2005 93 108 (Pubitemid 40126207)
20. M.J. Field, S. McCleary, J. Hughes, and L. Singh Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat Pain 80 1999 391 398 (Pubitemid 29151725)
21. E. Frederics, T. Christoph, and H. Buschmann Anangesics and antipretics J.L. McGuire, Pharmaceuticals 2 2000 Wiely-VCH Weinheim 341 434
22. B. Gao, M. Hierl, K. Clarkin, T. Juan, H. Nguyen, M. Valk, H. Deng, W. Guo, S.G. Letho, D. Mastson, J.S. McDermott, J. Knop, K. Gaida, L. Cao, D. Waldon, B.K. Albrecht, A.A. Boezio, K.W. Copeland, J.C. Harmange, S.K. Springer, A.B. Malmberg, and S.I. McDonough Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain Pain 149 2010 33 49
23. M.W. Holladay, M.J. Dart, and J.K. Lynch Neuronal nicotinic acetylcholine receptors as targets for drug discovery J. Med. Chem. 40 1997 4169 4194 (Pubitemid 28042300)
24. M.W. Holladay, J.T. Wasicak, N.H. Lin, Y. He, K.B. Ryther, A.W. Bannon, J. Buckley, D.J. Kim, M.W. Decker, D.J. Anderson, J.E. Campbell, T.A. Kuntzweiler, D.L. Donnelly-Roberts, M. Piattoni-Kaplan, C.A. Briggs, M. Williams, and S.P. Arneric Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors J. Med. Chem. 41 1998 407 412 (Pubitemid 28093076)
25. Y.M. Hoybergs, R.L. Biermans, and T.F. Meert The impact of bodyweight and body condition on behavioral testing for painful diabetic neuropathy in the streptozotocin rat model Neurosci. Lett. 436 2008 13 18
26. K.K. Jain A guide to drug evaluation for chronic pain Expert Opin. Emerg. Drugs 5 2000 241 257 (Pubitemid 30453626)
27. A.A. Jensen, B. Frolund, T. Liljefors, and P. Krogsgaard-Larsen Neuronal nicotinic acetylcholine receptors: structure revelations, target identifications, and therapeutic inspirations J. Med. Chem. 48 2005 4705 4745 (Pubitemid 41038456)
28. J. Ji, W.H. Bunnelle, D.J. Anderson, C. Faltynek, T. Dyhring, P.K. Ahring, L.E. Rueter, P. Curzon, M.J. Buckley, K.C. Marsh, A. Kempf-Grote, and M.D. Meyer A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo [3.2.0]-heptane α4β2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models Biochem. Pharmacol. 74 2007 1253 1262 (Pubitemid 47417939)
29. J. Ji, M.R. Schrimpf, K.B. Sippy, W.H. Bunnelle, T. Li, D.J. Anderson, C. Faltynek, C.S. Surowy, T. Dyhring, P.K. Ahring, and M.D. Meyer Synthesis and structure-activity relationship studies of 3,6-diazabicyclo [3.2.0] heptanes as novel α4β2 nicotinic acetylcholine receptor selective agonists J. Med. Chem. 50 2007 5493 5508 (Pubitemid 350057859)
30. S.K. Joshi, J.P. Mikusa, B. Weaver, and P. Honore Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain J. Pain 9 2008 146 156
31. J.D. Kennedy Neuropathic pain: molecular complexity underlies continuing unmet medical need J. Med. Chem. 50 2007 2547 2556 (Pubitemid 46896058)
32. A.C. Kesingland, C.T. Gentry, M.S. Panesar, M.A. Bowes, J.M. Vernier, R. Cube, K. Walker, and L. Urban Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain Pain 86 2000 113 118 (Pubitemid 30211710)
33. I.M. Khan, S. Stanislaus, L. Zhang, P. Taylor, and T.L. Yaksh A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception J. Pharmacol. Exp. Ther. 297 2001 230 239 (Pubitemid 32242583)
34. S.H. Kim, and J.M. Chung An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 1992 355 363
35. K.J. Kim, Y.W. Yoon, and J.M. Chung Comparison of three rodent neuropathic pain models Exp. Brain Res. 113 1997 200 206 (Pubitemid 27090842)
36. J.J. Lynch III, C.L. Wade, J.P. Mikusa, M.W. Decker, and P. Honore ABT-594 (a nicotinic acetylcholine agonist): antiallodynia in a rat chemotherapy-induced pain model Eur. J. Pharmacol. 509 2005 43 48 (Pubitemid 40248784)
37. J.A. Mitchell, and T.D. Warner COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs Nat. Rev. Drug Discov. 5 2006 75 86
38. N. Nozaki-Taguchi, S.R. Chaplan, E.S. Higuera, R.C. Ajakwe, and T.L. Yaksh Vincristine-induced allodynia in the rat Pain 93 2001 69 76 (Pubitemid 32530844)
39. C. Qian, T. Li, T.Y. Shen, L. Libertine-Garahan, J. Eckman, T. Biftu, and S. Ip Epibatidine is a nicotinic analgesic Eur. J. Pharmacol. 250 1993 13 14
40. L.M. Rorick-Kehn, B.G. Johnson, K.M. Knitowski, C.R. Salhoff, J.M. Witkin, K.W. Perry, K.I. Griffey, J.P. Tizzano, J.A. Monn, D.L. McKinzie, and D.D. Schoepp In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders Psychopharmacology 193 2007 121 136 (Pubitemid 46906627)
41. M.C. Rowbotham, W.R. Duan, J. Thomas, W. Nothaft, and M.M. Backonja A randomized, double blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain Pain 146 2009 245 252
42. L.E. Rueter, M.D. Meyer, and M.W. Decker Spinal mechanisms underlying A-85380-induced effects on acute thermal pain Brain Res. 872 2000 93 101 (Pubitemid 30618891)
43. L.E. Rueter, K.L. Kohlhaas, P. Curzon, C.S. Surowy, and M.D. Meyer Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain Pain 103 2003 269 276 (Pubitemid 36638816)
44. L.E. Rueter, D.L. Donnelly-Roberts, P. Curzon, C.A. Briggs, D.J. Anderson, and R.S. Bitner A-85380: a pharmacological probe for the preclinical and clinical investigation of the α4β2 neuronal nicotinic acetylcholine receptor CNS Drug Rev. 12 2006 100 112 (Pubitemid 44313714)
45. Z. Seltzer, R. Dubner, and Y. Shir A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218 (Pubitemid 20385185)
46. J.P. Sullivan, D. Donnelly-Roberts, C.A. Briggs, D.J. Anderson, M. Gopalakrishnan, M. Piattoni-kaplan, J.E. Campbell, D.G. McKenna, E. Molinari, A.-M. Hettinger, D.S. Garvey, J.T. Wasicak, M.W. Holladay, M. Williams, and S.P. Arneric A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand Neuropharmacology 35 1996 725 734 (Pubitemid 26308549)
47. N.R. Sullivan, L. Leventhal, J. Harrison, V.A. Smith, T.A. Cummons, T.B. Spangler, S.C. Sun, P. Lu, A.J. Uveges, B.V. Strassle, M.J. Piesla, R. Ramdass, A. Barry, J. Schantz, W. Adams, G.T. Whiteside, A. Adedoyin, and P.G. Jones Pharmacological characterization of the muscarinic agonist (3R,4R)-3-(3- hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo [2.2.1] heptane (WAY-132983) in in vitro and in vivo models of chronic pain J. Pharmacol. Exp. Ther. 322 2007 1294 1304 (Pubitemid 47295819)
48. J.H. Uhm, and W.K.A. Yung Neurologic complications of cancer therapy Curr. Treat. Options Neurol. 1 1999 428 437
49. W. Xiao, A. Boroujerdi, G.J. Bennett, and Z.D. Luo Chemotherpy evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit Neuroscience 144 2007 714 720 (Pubitemid 44856756)